Iclusig 30 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25F6ACY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $85,894
Award facts
- Contract value 100% obligated
- $85,894.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $85,894.40 on August 11, 2025, for the supply of ICLUSIG 30 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of September 2, 2025, was issued under the Defense Logistics Agency's SPE2DB Indefinite Delivery Contract program and is funded through the Defense Department's Medical Supply Chain. No set-aside designation was applied to this award, allowing the vendor to compete on an open basis despite its woman-owned small business status. The place of performance is the vendor's facility in Park Ridge, Illinois.
ICLUSIG (ponatinib) is a prescription oncology medication used in the treatment of certain blood cancers, reflecting DMS Pharmaceutical Group's established role as a critical supplier of specialized pharmaceutical products to military and federal healthcare facilities. This delivery order represents one of numerous pharmaceutical procurement actions issued under the company's $500 million IDC with the Defense Logistics Agency, which provides the agency with access to a comprehensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare operations worldwide through November 2026.
Quick answers
Who was awarded contract SPE2DX25F6ACY?
SPE2DX25F6ACY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2DX25F6ACY worth?
The government has obligated $85,894 on SPE2DX25F6ACY.
Is contract SPE2DX25F6ACY an order under another contract?
Yes. SPE2DX25F6ACY is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ACY competed?
The extent of competition for SPE2DX25F6ACY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award